NCT04841538 2022-04-29A Study of ES101 (PD-L1x4-1BB Bispecific Antibody) in Patients With Advanced Malignant Thoracic TumorsElpiscience Biopharma, Ltd.Phase 1/2 Withdrawn
NCT02941601 2019-09-27A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Naïve Participants With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)Eli Lilly and CompanyPhase 2 Withdrawn